Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals
Author(s) -
David Cipolla,
Huiying Wu,
Igor Gonda,
HakKim Chan
Publication year - 2015
Publication title -
journal of aerosol medicine and pulmonary drug delivery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.678
H-Index - 68
eISSN - 1941-2703
pISSN - 1941-2711
DOI - 10.1089/jamp.2015.1241
Subject(s) - chromatography , dynamic light scattering , pulmonary surfactant , chemistry , liposome , polyvinyl alcohol , vesicle , polysorbate , drug delivery , sonication , centrifugation , zeta potential , nanoparticle , materials science , nanotechnology , membrane , biochemistry , organic chemistry
Previously we showed that the release properties of a liposomal ciprofloxacin (CFI) formulation could be attenuated by incorporation of drug nanocrystals within the vesicles. Rather than forming these drug nanocrystals during drug loading, they were created post manufacture simply by freezing and thawing the formulation. The addition of surfactant to CFI, either polysorbate 20 or Brij 30, provided an additional means to modify the release profile or incorporate an immediate-release or 'burst' component as well. The goal of this study was to develop a CFI formulation that retained its nanocrystalline morphology and attenuated release profile after delivery as an inhaled aerosol.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom